Mast cells

They have nothing to do with masts, and were named (again by Ehrlich) from the German mästen, meaning “to fatten or force-feed”, because they appeared to be stuffed, plump, packed full of acidic granules. As such, we should refer to them as mäst cells. The distinction between these and basophils was so fine that up until the 1970s many considered basophils to be some kind of redundant circulating mast cell.  "Circulating" is the main distinction, as mast cells are generally held to be a tissue-resident cell.

In summary:

  • Mast cell structure
    • Nucleus: Solitary and round nucleus
    • Granules: about 1,000 per cell, comprising 50% of cell volume.
      • Contain anionic glycosaminoglycans like heparin, which bind cationic inflammatory molecules.
      • Cationic molecules include histamine, serotonin, chymase, and tryptase.
    • Staining: Granules stain with cationic dyes due to their anionic content.
  • Mast cell distribution and fate
    • Released from bone marrow as immature precursors.
    • Mature in tissues over approximately 17 days.
    • Long-lived in tissues, persisting for months to years.
    • Located in connective tissue, especially loose layers under the skin, omentum, digestive tract, tongue, glans penis, and posterior pituitary.
    • Can reproduce outside the bone marrow until mature and terminally differentiated.
  • Mast cell functions
    • Antiparasitic defense ("weep and sweep" response): Enhance barrier functions of skin and mucosa to expel parasites. Release histamine and other mediators causing mucus production and smooth muscle contraction.
    • Proteolytic functions: chymase and tryptase
      • Degrade motility-inhibiting polypeptides like neurotensin
      • Activate inflammatory mediators like angiotensin II
      • Attract fibroblasts
      • Activate the contact system (kallikrein-like activity).
      • Cleave matrix components (type IV collagen, fibronectin) to facilitate leukocyte adhesion and migration.
  • Causes of increased mast cell numbers
    • Mastocytosis (cutaneous and systemic forms).
    • Variants like mastocytoma, urticaria pigmentosa, and mast cell leukemia.
  • Drugs that inhibit mast cell activity
    • Mast cell-specific chemotherapy:
      • Cladribine (causes mast cell apoptosis).
    • Inhibitors of mast cell proliferation:
      • Midostaurin (tyrosine kinase inhibitor blocking mast cell activation).
      • Masitinib (interferes with signal transduction pathways).
      • Avapritinib (selective KIT D816V inhibitor targeting specific mutations).
      • Dupilumab (IL-4 receptor blocker preventing proliferation signals).
    • Inhibitors of effector function:
      • Adrenaline (prevents histamine release).
      • Antihistamines (block histamine receptors; continuous infusions may be used).
      • Montelukast (leukotriene D4 receptor antagonist inhibiting degranulation).
      • Zileuton (5-lipoxygenase inhibitor reducing leukotriene synthesis).
      • Disodium cromoglycate (stabilizes mast cell membranes).
      • Vitamin C (increases histamine degradation and inhibits its formation).
    • Counter-regulatory agents:
      • Omalizumab (anti-IgE monoclonal antibody).

This chapter has zero relevance to any specific element of Section S  from the 2023 CICM Primary Syllabus, but mast cell biology could come up in questions about hypersensitivity reactions. A reader with the need to prepare for the CICM exams will therefore benefit from targeted reading about the role of mast cells in allergy, such as Theoharides & Kalogeromitros (2006). More detail than this would not be necessary, and could potentially lead to dangerous digressions into turtle biology.

Structure of mast cells

Mast cells would not be mästen without their colourful content. Of this, they are abundantly full, with the nucleus and other organelles entirely obscured by dense asurophilic granules. Helander & Bloom (1974) estimated that each cell contains about a thousand granules, and that each cell is about 50% granule by volume.  If you can see the nucleus, then it is usually solitary and round, whereas the basophil is bilobed, making the mast cell a "monocyte" of sorts. Yong (1997), like a wildlife photographer, reports that

"The morphological shape of mast cells vary according to their habitat. When in loose connective tissue they appear rounded but when in close apposition to blood vessels they are elongated or ovoid, while in dermal fibres they may be spindle shaped, stellate or filiform."

Those granules have a high affinity for cationic alkaline dye because they contain a crystalline matrix of anionic glycosaminoglycans, of which the dominant one is again heparin, which again plays a structural role as the binding substrate for cationic inflammatory molecules, which include:

  • Histamine
  • Serotonin
  • Chymase 
  • Tryptase, a 130 kDa serine protease which we measure following episodes of anaphylaxis

Histamine is the main one of these preformed mediators - Yong mentions -100 mmol/L, or 2-3 pg per cell, but other authors mention values as high as 40 pg. Using the appendices from Sender et al to calculate the average mass of a mast cell, that's actually not much, as each mast cell weighs about 1000-2000 pg on average (i.e. about as much as a medium-sized macrophage. Other content is less massive but more active (i.e. some might argue that mast cell tryptase does more than histamine to define the role of the mast cell in inflammation).

Distribution and life cycle of mast cells

Unlike basophils, who are released from the marrow in a mature form, mast cells are released as immature precursors and finish their development when they come to rest in the tissues. It also appears that they can reproduce outside the bone marrow, though this probably stops once they are mature and terminally differentiated.  The pro-mastocytes released from the marrow seem to spend about 17 days reaching maturity, and thereafter persist in tissues for an extremely long time. Padawer (1974) found some previously injected throium granules were persisting in these cells 10 months later. They hang out in the connective tissue, predominantly in the loose layers under the skin, in the omentum, and around the digestive tract. For some weird reason they also accumulate in the tongue, the glans of the penis,  and the posterior pituitary, to name a few unexpectedly mast-cell-enriched spaces.

Function of mast cells

Like basophils mast cells seem to have an antiparasitic function mostly related to the enhancement of the normal barrier functions of the skin and mucosa, by making these defensive structures even more hostile to macroscopic invaders. This "weep and sweep" response is even harder to accommodate into the usual military metaphor for the immune system, which would stretch unnaturally into some kind of sci-fi nightmare where erected fortifications contract forcefully to shrug off the grappling hooks and ladders of the invading army, and wash them down the hill with torrents of mucus. Histamine does most of the work here, but other degranulated content also plays various roles in weeping and sweeping:

  • Proteolytic functions:
    • Chymase:
      • degrades neurotensin, a gut polypeptide that normally inhibits motlytiy
      • cleaves angiotensin I to angiotensin II (it has a proinflammatory effect)
      • attracts fibroblasts
    • Tryptase
      • Degrades other vaguely dilatory and antikinetic peptides like vasoactive intestinal polypeptide, peptide histidine methionine, and the vasodilator calcitonin gene-related peptide
      • Notably, ignores the bronchoconstrictor neuropeptide substance P
      • Performs a kallikrein-like activity, activating the contact system
      • Cleaves matrix components including type IV collagen and fibronectin, presumably to permit easier leukocyte adhesion and migration

That kind of antiparasitic response should probably be regarded as standard operating procedure of any sensible organism that does not routinely have access to a sink in which to wash their food, and indeed it seems that the last common ancestor we have what didn't  have mast cells would have been something pre-chordate, before our departure from the lineage of hagfish and lampreys.  Baccari et al (2011) speculate that these cells evolved to man the immune parapet from a very early stage, as even in the most distant relatives they are positioned in exactly the same anatomical locations (skin, intestinal mucosa, tongue, etc). 

Causes of increased and decreased mast cell numbers 

Mast cells would not be expected to appear in the bloodstream, which means the disorders of mast cell proliferation are mostly limited to increased tissue mastocytes. Metcalfe (2008) is the best quick reference for the range of this, which seems to be limited to mastocytosis. This rare disorder is subclassified as cutaneous and systemic, depending on the tissue distribution of the abnormal cells, and has a range of even rarer variants, such as mastocytoma, urticaria pigmentosa and mast cell leukaemia.

Drugs that influence mast cell activity

Under the vast majority of circumstances, one does not wish to specifically enhance the activity of mast cells; one's clinical activities are much more likely to be focused on their suppression. This is fortunate, as mast cell suppression has a surprisingly rich pharmacological arsenal.  Molderings et al (2016) list several options:

  • Mast cell specific chemotherapy
  • Inhibitors of mast cell proliferation
    • midostaurin, a small-molecule inhibitor of multiple type III tyrosine kinase receptor, which blocks mast cell expansion and activation
    • masitinib, another TKI that interferes with signal transductions for numerous pathways
    • avapritinib, a selective KIT D816V inhibitor (i.e. it targets a specific mutation)
    • dupulimab (an  IL-4 receptor blocker that prevents mast cells from receiving their usual proliferation signals)
  • Inhibitors of effector function:
  • Counter-regulatory agents:

References

Theoharides, Theoharis C., and Dimitrios Kalogeromitros. "The critical role of mast cells in allergy and inflammation." Annals of the new York Academy of Sciences 1088.1 (2006): 78-99.

Fernex, Michel. The mast-cell system. Basel and New York: Karger, 1968.

Yong, L. C. J. "The mast cell: origin, morphology, distribution, and function." Experimental and Toxicologic Pathology 49.6 (1997): 409-424.

Church, Martin K., and Francesca Levi-Schaffer. "The human mast cell." Journal of Allergy and Clinical Immunology 99.2 (1997): 155-160.

Combs, J. W., D. Lagunoff, and E. P. Benditt. "Differentiation and proliferation of embryonic mast cells of the rat." The Journal of cell biology 25.3 (1965): 577-592.

Sugiura, H. I. S. A. S. H. I., and M. A. S. A. M. I. Uehara. "Mitosis of mast cells in skin lesions of atopic dermatitis." Acta dermato-venereologica 73.4 (1993): 296-299.

Padawer, Jacques. "Mast cells: extended lifespan and lack of granule turnover under normal in vivo conditions." Experimental and molecular pathology 20.2 (1974): 269-280.

Helander, Herbert F., and Gunnar D. Bloom. "Quantitative analysis of mast cell structure." Journal of microscopy 100.3 (1974): 315-321.

Dvorak, Ann M. "Ultrastructural studies of human basophils and mast cells." Journal of Histochemistry & Cytochemistry 53.9 (2005): 1043-1070.

Crivellato, Enrico, and Domenico Ribatti. "The mast cell: an evolutionary perspective." Biological Reviews 85.2 (2010): 347-360.

Baccari, Gabriella Chieffi, et al. "Mast cells in nonmammalian vertebrates: an overview." International review of cell and molecular biology 290 (2011): 1-53.

Metcalfe, Dean D. "Mast cells and mastocytosis." Blood, The Journal of the American Society of Hematology 112.4 (2008): 946-956.

Molderings, Gerhard J., et al. "Pharmacological treatment options for mast cell activation disease." Naunyn-Schmiedeberg's Archives of Pharmacology 389.7 (2016): 671-694.

Valent, Peter, et al. "Midostaurin: a magic bullet that blocks mast cell expansion and activation." Annals of Oncology 28.10 (2017): 2367-2376.